Yeast vacuole fusion requires palmitoylated Vac8. We previously showed that Vac8 acylation occurs early in the fusion reaction, is blocked by antibodies against Sec18 (yeast N-ethylmaleimide-sensitive fusion protein (NSF)), and is mediated by the R-SNARE Ykt6. Here we analyzed the regulation of this reaction on purified vacuoles. We show that Vac8 acylation is restricted to a narrow time window, is independent of ATP hydrolysis by Sec18, and is stimulated by the ion chelator EDTA. Analysis of vacuole protein complexes indicated that Ykt6 is part of a complex distinct from the second R-SNARE, Nyv1. We speculate that during vacuole fusion, Nyv1 is the classical R-SNARE, whereas the Ykt6-containing complex has a novel function in Vac8 palmitoylation.
wise. Antibodies used were anti-hemagglutinin epitope (HA) monoclonal antibody (BabCO) and rabbit polyclonal antibodies against Vam3, Nyv1, Vti1, Vam7, Ykt6, Sec17 (14, 25) , and His-tagged GFP (this study). Unless indicated, Nyv1-HA was detected with anti-HA antibody. Antibodies to GFP were raised in New Zealand White rabbits and affinity-purified as described (14) using CNBr-Sepharose (Amersham Biosciences) immobilized pure protein. Preparations of IgGs and affinity-purified antibodies were as described (26) .
Yeast Strains and Molecular Biology-Saccharomyces cerevisiae strains are listed in Table I . Yeast were cultured in yeast extractpeptone-glucose. Nyv1 was C-terminally tagged with 6xHA by transformation of a PCR fragment containing the tag and a TRP1 marker into BJ3505 (CUY001) (27) . Construction of the yeast strain CUY1250 containing internally GFP-tagged Ykt6 was as follows. DKY6281 (CUY002) was transformed with pRS416-YKT6pr-YKT6
WT (47) , and endogenous YKT6 was deleted by replacement of the open reading frame with the KANMX4 selection marker (28) ; the resulting strain was unable to grow on synthetic medium containing 5Ј-fluoroorotic acid, confirming the ykt6 deletion. This strain was then transformed with the plasmid pRS423-YKT6pr-GFP int YKT6 (47) , and loss of pRS416- WT was induced by growth on 5Ј-fluoroorotic acid. For N-terminal tagging of Vam3 with glutathione S-transferase (GST), the genomic VAM3 open reading frame without start codon was PCRamplified and inserted into the GST-containing vector pGEX4T-3 (Amersham Biosciences). The new GST-VAM3 open reading frame was then amplified by PCR and inserted into the yeast integrative vector pRS406 (29) containing the NOP1 promoter. The plasmid pRS406-NOP1pr-GST-VAM3 was linearized in the URA3 marker and transformed into BJ3505 vam3⌬ (CUY010) and DKY6281 vam3⌬ (CUY012) (25) . Subsequent sequencing revealed that the Vam3 sequence has the point mutation K96E, affecting a non-conserved residue in helix C of the Nterminal extension. This does not affect the functionality of the protein, as detailed under "Results."
Recombinant Proteins-Purifications of Vac8-GST, His 6 -Sec18 E350Q, and His 6 -Sec18 from Escherichia coli were as described (8, 30) . His-tagged GFP, used for antibody production and affinity purification, was expressed from the plasmid pET15b-eGFP (kindly provided by W. Nickel, Biochemie-Zentrum der Universitä t Heidelberg) and purified from E. coli.
In Vitro Palmitoylation-BJ3505 vacuoles were incubated under fusion conditions at 26°C. Incubation times and time of [ Fig. 1 and 2 ). Where indicated Vac8-GST (15 g) was added. Vacuoles were pelleted (10 min, 12,000 ϫ g), resuspended in PK buffer (20 mM PIPES/KOH, pH 6.8, 120 mM KCl) containing 0.5ϫ protease inhibitor mixture (1ϫ protease inhibitor mixture ϭ 7.5 M Pefabloc SC, 7.5 ng/ml leupeptin, 3.75 M o-phenanthroline, and 37.5 ng/ml pepstatin (31)), and pelleted again. Vacuoles were resuspended in SDS sample buffer without 2-mercaptoethanol and analyzed by SDS-PAGE and fluorography.
For extract preparation, membranes from a 200-l reaction (as described above but without the addition of radioactive palmitate) were solubilized in 100 l of Triton buffer (0.25% Triton X-100, 120 mM KCl, 20 mM PIPES/KOH pH 6.8, 1ϫ protease inhibitor mixture) and incubated for 1 h at 4°C with agitation. Insoluble material was removed by centrifugation (15 min, 20 ,000 ϫ g, 4°C), and the supernatant (10 l, about 5 g of vacuoles) was incubated with [ 3 H]Pal-CoA in a total volume of 100 l (adjusted with PK buffer) at 26°C. Proteins were precipitated with trichloroacetic acid (13% v/v) and acetone and analyzed by SDS-PAGE and fluorography.
Vacuole Isolation and in Vitro Fusion-Vacuoles were isolated from the yeast strains BJ3505 (pep4⌬ prb1⌬) and DKY6281 (pho8⌬) by DEAE-dextran lysis and Ficoll gradient centrifugation. Fusion between these vacuoles was measured by a biochemical complementation assay as described (31) . Briefly, 2-3 g each of pep4⌬ and pho8⌬ vacuoles were incubated together at 26°C in 30 l of PS buffer containing protease inhibitor mixture (0.02ϫ/30 l), reaction salts (0.5 mM MgCl 2 , 0.5 mM MnCl 2 , 125 mM KCl), and CoA (10 M) in the presence or absence of an ATP-regenerating system (0.5 mM ATP, 40 mM creatine phosphate, 0.1 mg/ml creatine kinase). A colorimetric substrate, pnitrophenyl phosphate, for alkaline phosphatase was added to detergent-solubilized reactions, and the absorbance at 400 nm was measured. One unit of fusion activity is defined as the production of 1 mol of p-nitrophenol/min/g pep4⌬ vacuoles.
Where indicated, reactions also contained cytosol (0.5 mg/ml (30)), His 6 -Sec18 (200 ng/ml (30)), microcystin-LR (MCLR; 10 M; Alexis Biochemicals), or the recombinant Rab GDP-dissociation inhibitor, Gdi1 (10 M (31)). Large scale fusion reactions contained the same proportions of all reagents as above.
Affinity Purification-All experiments were with protease-deficient vacuoles (BJ3505 background) unless written otherwise. After incubation in a large scale fusion reaction (where indicated in the figures), vacuoles were diluted to 1.5 ml with PSK buffer (10 mM PIPES/KOH, pH 6.8, 200 mM sorbitol, 150 mM KCl), pelleted (5 min, 12,000 ϫ g, 4°C), washed once with 500 l of PSK buffer, and pelleted again. Membranes were detergent-solubilized in 1 ml of lysis buffer composed of 0.5% Triton X-100, 20 mM HEPES/KOH, pH 7.4, and 150 mM KCl (see below for exceptions). The following protease inhibitors were used: 1ϫ protease inhibitor mixture, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml ␣ 2 -macroglobulin (Roche Applied Science). Lysis was for 10 min on a nutator at 4°C. A fraction of the cleared extracts (10 min, 20,000 ϫ g, 4°C) was removed and trichloroacetic acid/acetone-precipitated. The remaining detergent extract was incubated with the appropriate affinity matrix overnight on a nutator at 4°C, and beads were washed in lysis buffer containing decreasing amounts of detergent (0.5%, 0.1%, 0.025% Triton X-100) before elution.
For Fig. 3B , vacuoles were solubilized in lysis buffer containing 0.5% Triton X-100, 20 mM PIPES/KOH, pH 6.8, and 150 mM KCl; in Fig. 3C , solubilization buffer was 0.1% Triton X-100, 20 mM HEPES/KOH pH 7.4, and 150 mM NaCl. Anti-GFP, anti-Sec17 or anti-Vti1 antibodies (0.1-1 l) were cross-linked to protein A-Sepharose (Amersham Biosciences), and proteins were eluted with 0.1 mM glycine, pH 2.5, and 0.025% Triton X-100 and trichloroacetic acid/acetone-precipitated.
Vacuolar trans-SNARE complexes were analyzed (Fig. 4D ) by immunoprecipitation of Nyv1-HA with anti-HA antibodies (0.1-1 l) bound to protein G-Sepharose (10 l; Amersham Biosciences); elution was by boiling in SDS sample buffer containing 2-mercaptoethanol. For tandem isolation of trans-SNARE complexes (Fig. 4E) , fusion reactions were diluted into 5 ml of PSK buffer, and vacuoles were collected, resuspended in 1 ml of PSK buffer, and isolated again prior to detergent lysis. Vacuole extracts were incubated for 2 h with glutathione-Sepharose 4B (15-40 l; Amersham Biosciences), and bound proteins were eluted with 1.5 ml of elution buffer (50 mM HEPES/KOH, pH 7.4, 150 mM KCl, 0.1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 20 mM reduced GSH). Eluates were then incubated with protein G-Sepharose/anti-HA antibody overnight at 4°C. Beads were washed twice for 10 min with lysis buffer containing 0.5% and then 0.1% Triton X-100 and then for 10 min with lysis buffer containing 300 mM KCl and 0.025% Triton X-100. Proteins were eluted by boiling in reducing sample buffer.
For size analysis of SNARE complexes (Fig. 4F) , vacuole detergent extracts were centrifuged on continuous glycerol density gradients (10 -30%, 18 h, 250,000 ϫ g, 4°C, SW40 rotor). 1-ml fractions were collected, incubated with GSH-Sepharose overnight on a nutator at 4°C, and This study washed and eluted by boiling in SDS sample buffer. Proteins were analyzed by 12% SDS-PAGE and Western blotting (see figure legends for methods not discussed under "Experimental Procedures").
RESULTS

Vac8 Palmitoylation on Isolated Vacuoles Does Not Require Exogenous ATP and Is Restricted to a Narrow Time Window during Vacuole
Fusion-On isolated yeast vacuoles, Vac8 becomes palmitoylated in a reaction parallel to the Sec18/17-and ATP-dependent priming reaction (14) . Vac8 palmitoylation is sensitive to antibodies against Sec18 but is insensitive to Sec17 antibodies (14) . Since Sec17 is required for Sec18 to hydrolyze ATP (32) Vac8 labeling by SDS-PAGE and fluorography. Surprisingly, Vac8 acylation was more efficient in the absence of ATP (Fig.  1A) , even though ATP-dependent priming and fusion were inhibited ( Fig. 2A, C) . This shows that ATP addition is not necessary for Vac8 acylation and, together with the Sec17 antibody data, indicates that palmitoylation is independent of the Sec18 ATPase activity. In addition, our results show that the palmitoylation reaction is regulated, as it occurs within a narrow time frame; with or without ATP, maximal palmitoylation was achieved early in the reaction (Fig. 1A) and was restricted to this interval (Fig. 1B) . The temporal restriction of palmitoylation could be due to either a decreasing availability of substrate (Vac8, Pal-CoA) or inactivation of the palmitoylating activity. To distinguish between these possibilities, we incubated vacuoles with or without ATP and, 
FIG. 2. Different functions of Sec18 in palmitoylation and priming.
A, EDTA blocks ATP-dependent release of Sec17 from vacuoles. BJ3505 vacuoles were incubated for 10 min at 26°C in a 150-l reaction containing cytosol, CoA, and His 6 -Sec18 in the presence or absence of ATP-regenerating system and EDTA (1 mM). Vacuoles were re-isolated, washed twice with 500 l of PSK buffer, and analyzed by immunoblotting with anti-Sec17 antibodies. B, EDTA enhances Vac8 palmitoylation. The experiment was identical to that described in A, except that it was twice as large and contained [ 3 H]palmitate (150 Ci), and if present, ATP was without the regenerating system. Palmitoylated Vac8 was identified by non-reducing SDS-PAGE and fluorography. C, ATPase-deficient Sec18 E350Q blocks fusion but not palmitoylation. The indicated concentrations of Sec18 E350Q were added to fusion reactions, and fusion was determined after 90 min (see "Experimental Procedures"). The corresponding concentrations (as in B) of Sec18 E350Q were included in palmitoylation reactions. Quantification of the relative incorporation of radioactivity by laser densitometry shows no significant difference in lanes 2-5. D, Sec18 E350Q inhibits ATP-dependent Sec17 release. Reactions were performed as described in A. Where indicated, 2 M Sec18 E350Q or wild type was added to the reaction.
at defined time points, added recombinant Vac8-GST and [ 3 H]Pal-CoA for an additional incubation of 10 min. When Vac8-GST and [
3 H]Pal-CoA were added after 10 min, the labeling of both endogenous and exogenous Vac8 was significantly decreased (Fig. 1B) . This indicates that the palmitoylating activity becomes down-regulated during the incubation. We previously showed that this activity can be recovered from detergent-solubilized vacuoles (14, 24) . In contrast to our observations using intact vacuoles (Fig. 1A,  B) , these extracts do not lose their ability to mediate Vac8 acylation over time (24) . We therefore asked whether we could use detergent extraction to rescue the ability of Vac8 to be palmitoylated at a later time point. For this, we incubated vacuoles for 0 and 15 min at 26°C and then either labeled them directly with [
3 H]Pal-CoA (Fig. 1C, top right panel) or first solubilized the vacuoles with detergent and then added [ 3 H]Pal-CoA (Fig. 1C, bottom right panel) . As expected, intact vacuoles lost their ability to acylate Vac8 after 15 min. In contrast, Vac8 was efficiently labeled from extracts prepared at either time point. The fact that temporal control of Vac8 acylation is removed by extraction indicated to us that this activity is regulated by structural rearrangements on the vacuole. The task was then to find out more about the nature of this vacuole-specific control mechanism. We previously demonstrated that antibodies to Sec18 inhibit Vac8 acylation on isolated vacuoles (8), whereas Sec18 is not involved in acylation after detergent extraction (14) . This suggests Sec18 as a potential regulator of spatiotemporally controlled Vac8 acylation. Furthermore, Sec18, Vac8, and the SNARE Ykt6, which we identified as responsible for Vac8 acylation, are found in association with the cis-SNARE complex (24), suggesting that a better understanding of this complex might lend insight into the control of Vac8 acylation. Therefore, we examined the possible involvement of Sec18 and the cis-SNARE complex in regulating palmitoylation.
ATP Hydrolysis by Sec18 Is Not Required for Vac8
Acylation-The priming reaction of in vitro vacuole fusion (i.e. cis-SNARE disassembly and Sec17 release) (22, 23) requires Sec17 and added ATP (22) . However, Sec18-dependent acylation of Vac8 is insensitive to anti-Sec17 antibodies (14) and does not require the addition of ATP (Fig. 1, A and B) . To directly test whether the Sec18 function in Vac8 acylation is independent of ATP hydrolysis, we used two established methods to inhibit the ATPase activity of Sec18. First, we incubated vacuoles in the presence of the divalent cation chelator EDTA, which blocks the ability of Sec18 to disassemble SNARE complexes and the corresponding release of Sec17 from the vacuole ( Fig. 2A) (22) . Strikingly, EDTA did not inhibit Vac8 palmitoylation but, rather, stimulated it (Fig. 2B) . Stimulation by EDTA might be due to chelation of Zn 2ϩ ions that are known to interact with sulfhydryl groups (33), although additional experiments are necessary to clarify this point. Importantly, this observation suggested that the palmitoylation activity does not require, or is even more robust without, ATP hydrolysis by Sec18. We therefore hypothesized that a Sec18 mutant homologous to the Drosophila melanogaster comatose mutant (Sec18 E350Q (34, 35) ), which cannot hydrolyze ATP, would interfere with vacuole fusion but not palmitoylation. Vacuole fusion is assayed by a biochemical complementation assay that measures content mixing (see "Experimental Procedures"). When we titrated purified Sec18 E350Q into the assay, fusion was completely prevented, and indeed, palmitoylation of Vac8 was unaffected (Fig.  2C) . Inhibition of fusion was due to a block in priming, because Sec18 E350Q inhibited Sec17 release from the vacuole (Fig.  2D) . The presence of Sec18 E350Q, in contrast to EDTA, did not stimulate palmitoylation.
Positioning of the Ykt6 Protein in a Novel
Complex on Vacuoles-We previously showed that Ykt6 is required for palmitoylation of Vac8 (14) . This is supported by the proximity of Vac8 and Ykt6 on vacuoles and a function of the Ykt6 longin domain early in the fusion reaction (14) . Ykt6 was found to be associated with the vacuole cis-SNARE complex (16); however, this complex does not seem to be homogeneous. We analyzed cis-SNARE complexes on isolated vacuoles and found that although GFP-tagged Ykt6 interacts with the vacuolar Q-SNARE Vam3, it is not detectable with the second vacuolar R-SNARE, Nyv1 (Fig. 3A) . Moreover, in mutants lacking the Q-SNARE Vam7, Nyv1 is missing from the cis-SNARE complex, although it still contains the Q-SNAREs Vam3 and Vti1 (36). This is not merely a Q-SNARE complex, however, as it also contains the R-SNARE Ykt6 (Fig. 3, B and C) . These data demonstrate that the cis-SNARE complex is more heterogene-
FIG. 3. Analysis of Ykt6 and Nyv1 complexes.
A, analysis of the Ykt6 SNARE complex. Vacuoles from a strain containing only endogenous untagged Ykt6 (WT, wild type; CUY002) and a strain carrying internally GFP-tagged Ykt6 (CYU1250) as the sole Ykt6 copy (120 g each) were processed for anti-GFP co-immunoprecipitation (CoIP) as described under "Experimental Procedures." Equal amounts of vacuolar extract (input) and flow-through (FT) (5% each) are shown. Western blots were decorated with antibodies to Vam3, Nyv1, and Ykt6. B, analysis of Vti1 and Sec17 complexes. Wild-type and vam7⌬ vacuoles (60 g each) were incubated in fusion reactions with or without ATP for 10 min at 26°C, re-isolated, and processed as described in A. Half of the lysate was analyzed by anti-Vti1 co-immunoprecipitation and the other half with anti-Sec17 co-immunoprecipitation. An aliquot (2% of total) was removed prior to loading onto beads. Western blots were decorated with antibodies against Ykt6 and Vti1 or Sec17 as indicated. C, because the amounts of Nyv1 and Sec17 are reduced on vam7⌬ vacuoles, the anti-Sec17 co-immunoprecipitation in B was repeated with normalized protein amounts; 10% of the lysate was removed prior to loading on beads, and Western blots were decorated with antibodies against Nyv1 and Ykt6.
ous than previously appreciated. Since priming is not required for Ykt6-mediated palmitoylation of Vac8 (Figs. 1 and 2 ) and the cis-SNARE complex appears to be heterogeneous, we hypothesized that the cis-SNARE complex present on isolated vacuoles provides R-SNAREs for two pathways: 1) Ykt6, with the help of Sec18 in a function independent of priming, mediates Vac8 palmitoylation; 2) Nyv1, following Sec18/17-dependent priming, enters into the trans-SNARE complexes that drive homotypic vacuole fusion.
To determine the involvement of vacuolar R-SNAREs in the transition from cis-to trans-SNARE complexes, we decided to devise a new assay to compare these two complexes (Fig. 4) .
FIG. 4. Analysis of the Nyv1-containing trans-SNARE complexes.
A, vacuole localization of Nyv1-HA (N-HA) and GST-Vam3 (G-V3). Vacuoles (6 g) from the respective strains were lysed in SDS sample buffer, and SNAREs were identified by Western blotting with antibodies to Nyv1, Vam3, and Vti1; v3⌬, vam3⌬; wt, wild type (parent strain). B, in vivo analysis. Vacuoles in the indicated BJ3505 strains (see Table I ) were analyzed by pulse chase with FM4-64 (46) and fluorescence or phase contrast microscopy using a Zeiss Axiovert 35 fluorescence microscope. C, functionality of tagged SNAREs in vacuole fusion. Vacuoles from the indicated strains were fused in standard fusion reactions (see "Experimental Procedures") for 60 -90 min with ATP, with the addition of cytosol or recombinant Sec18p (ratio of tag to wild-type fusion was invariant). In each experiment, fusion from a reaction without ATP was subtracted and fusion was compared with wild type (set to 100%; average wild-type units ϭ 2.6). The graph represents values averaged from multiple experiments. Error bars are standard deviations among several independent experiments; n⌬ ϭ nyv1⌬. D, specificity of trans-complex formation confirmed by inhibitors. Vacuoles were incubated in the presence of cytosol with either no ATP, ATP alone, or ATP with the late-stage fusion inhibitor MCLR or the tethering inhibitor Gdi1, as described under "Experimental Procedures." The graph shows in vitro fusion between BJ Nyv1-HA/DKY GST-Vam3 vacuoles (3 g each). Control reactions with ATP/no inhibitor were set to 100%. Error bars are standard deviations among n experiments: ϪATP ϭ 10; ϩATP (no inhibitor control) ϭ 10; MCLR (10 M) ϭ 7; recombinant Gdi1 (9 M) ϭ 2. In the Western, large scale fusion reactions containing 40 g each of Nyv1-HA and GST-Vam3 (both BJ3505) and the reaction components described above were incubated for 30 min at 26°C. Vacuoles were re-isolated and detergent-solubilized, and 2% of them were removed and trichloroacetic acid-precipitated (the ϩATP sample is shown), and protein complexes were analyzed by anti-HA co-immunoprecipitation (co-IP) (see "Experimental Procedures" for details). Lanes are from a single representative gel but are arranged in the figure as indicated by white spaces. Blots were decorated with anti-Vam3 followed by anti-HA antibodies. E, affinity isolation of the trans-SNARE complex. A schematic diagram of the assay is shown. Fusion reactions (2.25 ml) containing 225 g each of GST-Vam3 and Nyv1-HA vacuoles were incubated with 10 M MCLR Ϫ/ϩ ATP for 30 min. Lysis of vacuoles and sequential isolation of complexes by GSH pull-down, and anti-HA immunoprecipitation was as described under "Experimental Procedures." Proteins were analyzed by SDS-PAGE and Western blotting with the indicated antibodies. F, sizing of wild-type cis-and trans-SNARE complexes. Vacuoles were treated as described in E through the solubilization step, and extracts were fractionated by ultracentrifugation on 10 -30% continuous glycerol density gradients (18 h, 250,000 ϫ g, 4°C, SW40 rotor; 1 ϭ top of gradient) and then subjected to GSH pull-downs (see "Experimental Procedures"). Complexes were analyzed by Western blotting with the indicated antibodies. Sizes were determined by a parallel marker-mixture gradient (Amersham Biosciences). The sizes (in kDa) of marker proteins and their corresponding gradient fractions are indicated.
The existing assay of trans-SNARE pairing is based on the establishment of Vam3/Nyv1 interactions, in trans, between nyv1⌬ and vam3⌬ vacuoles (37). Vam3 is the "heavy chain" of the vacuolar Q-SNARE complex containing Vam3, Vam7, and Vti1 and is required for fusion of vacuoles (25, 37) and liposomes (38); in both assays, Nyv1 was identified as the valid R-SNARE (25, 37, 38) . Because SNARE mutants were used, however, this assay precludes a comparison of trans-SNAREs with cis-SNAREs and permits analysis of only binary interactions between Vam3 and Nyv1; complete trans-SNARE complexes between biological membranes have been uncharacterized until now.
For our new assay, we tagged Vam3 in one strain and Nyv1 in the other, so that a mixture of vacuoles purified from these strains would form doubly tagged trans-SNARE complexes. Vam3 was tagged at its N terminus with GST, and Nyv1 was C-terminally 6xHA-tagged. Both proteins behave like their untagged counterparts, based on the criteria of vacuole localization (Fig. 4A) , vacuole morphology (Fig. 4B) , and in vitro vacuole fusion (Fig. 4C) , indicating that neither tag interferes with SNARE function. Thus, our new assay uses vacuoles with wildtype characteristics.
Nyv1-HA/GST-Vam3 SNARE pairs are detected when vacuoles carrying the respective tags are incubated together under normal fusion conditions, solubilized, and subject to affinity precipitation with anti-HA antibodies or GSH beads (Fig. 4D and data not shown). Complexes are prevented when priming or tethering are blocked by withholding, respectively, ATP or Gdi1 inactivation of the Rab GTPase Ypt7 (39) , showing that they form in line with the fusion reaction and prior to solubilization. Authentic trans-SNARE pairs, i.e. formed in trans prior to fusion rather than as a result of fusion, are observed when vacuoles are incubated with the late-stage fusion inhibitors MCLR (40, 41), 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA) (7, 42) , or GTP␥S (40, 43) (Fig. 4D and data not shown) .
Using our newly established assay, we determined the composition of trans-SNARE complexes and compared it with the vacuolar cis-complex. To detect complete trans-SNARE complexes rather than binary SNARE interactions, we took advantage of the reversible association of GST-Vam3 with GSH beads. SNARE complexes were enriched on GSH beads, released by the addition of reduced glutathione to maintain complex integrity, and re-isolated with HA antibodies, so that only those proteins that stably associate with trans-interacting GST-Vam3 and Nyv1-HA were recovered (Fig. 4E ). Vti1 and Vam7 co-purified with the trans-SNARE complex, whereas Sec17 and Ykt6 are absent (Fig. 4E and data not shown) .
In order to confirm the absence of Ykt6 from Nyv1-containing trans-SNARE complexes, we determined the size of complexes containing trans-interacting GST-Vam3 and Nyv1-HA. Vacuoles were incubated with ATP and a fusion inhibitor (as described above), to allow for trans-SNARE formation, and then detergent-solubilized. The extract was then centrifuged through a 10 -30% glycerol gradient, and complexes between Nyv1-HA and GST-Vam3 were analyzed by GSH pull-downs of the individual fractions. As shown in Fig. 4F , Nyv1-HA/GSTVam3 complexes were isolated from fractions corresponding to a size of 10 S. This suggests that Vam3, Vam7, Vti1, and Nyv1 form the trans-SNARE complex core, in keeping with the requirement of these four SNAREs for liposome fusion (38) . Ykt6 was not found in the Nyv1-containing trans-SNARE complex (Fig. 4F, right) . This is consistent with our observation that vacuolar cis-SNARE complexes do not contain both Nyv1 and Ykt6 (Fig. 3A) . Multimerization of cis-SNARE complexes, or the segregation of higher order complexes into different membrane domains, might have allowed previous co-purification of Nyv1 and Ykt6 under less stringent conditions (16) .
We suggest, based on the current data, that there are different vacuolar subcomplexes containing one or the other core R-SNARE. Nyv1 appears to form classical, four-helix bundle SNARE complexes, whereas Ykt6 has a unique function with Sec18 in coordinating palmitoylation of the fusion factor Vac8. DISCUSSION We previously reported that Vac8 is palmitoylated during an early stage of vacuole fusion (8) . This reaction is mediated by the SNARE Ykt6 (14) . Vac8 association with vacuolar SNAREs and inhibition of palmitoylation by Sec18 antibodies suggested that priming might be required for palmitoylation. However, since Sec17 antibodies did not inhibit Vac8 palmitoylation, we suspected that Sec18 has a novel role in the palmitoylation reaction (14) . Here, we have shown that this potential role of Sec18 is indeed independent of cis-SNARE disassembly, as it does not require ATP hydrolysis. EDTA and an ATP hydrolysisdefective Sec18 protein (E350Q) both blocked fusion but did not inhibit palmitoylation. One possible explanation for this is that Sec18 is not directly involved in the regulation of Vac8 palmitoylation and that the inhibition by anti-Sec18 is steric. This would be intriguing because other antibodies that recognize the cis-complex do not have this effect, and it might give insights into the architecture of the palmitoylation complex. Alternatively, Sec18 could be directly implicated in promoting Vac8 acylation in an ATP-independent manner. This would occur in parallel or prior to the ATP-and Sec17-dependent function of Sec18 in cis-SNARE complex disassembly (14) . As neither Sec18-dependence (14) nor temporal regulation of the palmitoylating activity was observed for vacuolar extracts (Fig. 1) , we speculate that Sec18 is implicated in rearrangements of vacuole protein complexes that link palmitoylation to the rest of the fusion reaction. Early studies on vacuole fusion revealed a salt-and temperature-dependent "stage I" that occurs independent of and prior to the ATP-dependent priming stage (44) . Vac8 palmitoylation requires salt and incubation at a physiological temperature (24) but does not need ATP; perhaps, then, Vac8 palmitoylation corresponds to stage I, which may involved Sec18 in an unconventional role. This would raise the possibility that completion of stage I is the ATP-and primingindependent signal that terminates Vac8 palmitoylation on vacuoles.
How do we define the cis-complex, with which Ykt6, Sec18, and Vac8 are associated, that is responsible for the regulation of palmitoylation? A previous study reported that Ykt6, under mild purification conditions, is in a complex with multiple vacuolar SNAREs, including the R-SNARE Nyv1 (16) . Our present analysis of SNARE complexes on wild-type and mutant membranes (Figs. 3 and 4) , however, reveals a different picture. We found that SNARE complexes isolated from vacuoles contain either Nyv1 or Ykt6, consistent with the findings from studies with liposomes that Nyv1 and Ykt6 are mutually exclusive in SNARE complexes (38) . We conclude that the previous stoichiometric co-isolation of Ykt6 and Nyv1 was most likely a result of the lateral association of distinct complexes and that the vacuolar cis-complex is more heterogeneous than thus far appreciated.
If Nyv1 forms the trans-SNARE complexes that drive homotypic vacuole fusion, why does vacuole fusion require an additional R-SNARE complex? We previously showed that vacuole fusion first gains resistance to Ykt6 antibodies and only later (at docking) does it become resistant to antibodies against the other vacuolar SNAREs. Ykt6 itself is a palmitoylated protein, both in humans (20) and in yeast (47) . We also recently found that Ykt6 undergoes priming-dependent release from vacuoles, by a mechanism that might require its depalmitoylation. Thus, it appears that during homotypic vacuole fusion, Ykt6 does not behave as a classical SNARE. Instead, it might take advantage of its association with vacuolar SNAREs (indeed, it is required as a SNARE for traffic to the vacuole (17, 45) ) to participate in other fusion subreactions such as Vac8 palmitoylation.
We are beginning to understand how palmitoylation at the vacuole is controlled. We propose the following working model for Ykt6-mediated palmitoylation of Vac8. On isolated vacuoles, Vac8 is associated with a cis-SNARE subcomplex that contains Ykt6. Ykt6, with the help of Sec18, transfers its palmitate to Vac8. This is a priming-independent reaction (parallel or prior to priming) that, nevertheless, is under strict spatiotemporal control. Ykt6 remains tightly associated with the vacuole because it is part of a cis-SNARE complex four-helix bundle. Following priming, Ykt6 dissociates from its SNARE partners and, having lost its stable lipid anchor, falls off the membrane.
In conclusion, we have found that Vac8 palmitoylation must be limited to a specific window of vacuole fusion, which is controlled by a specialized, Ykt6-containing cis-SNARE subcomplex. A detailed analysis of this Ykt6 complex will be an important task for future research.
